GlaxoSmithKline (GSK) has launched cervical cancer vaccine, Cerverix, in India. The vaccine, which is proved to be effective and safe without any alarming side effects, is targeted towards the 132000 Indian women diagnosed with human papillomavirus (HPV) that causes cervical cancer. GSK is in talks with the government to make HPV vaccine easily accessible in India. At present, only two HPV vaccines are available in the market - GSK's Cerverix and Merck's Gardasil.
The details cane be read here.
No comments:
Post a Comment